Infectious complications in bone marrow transplantation
Author(s)
Bibliographic Information
Infectious complications in bone marrow transplantation
(Recent results in cancer research, 132)
Springer-Verlag, c1993
- : gw
- : us
Available at 10 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
As the demographics of the population shift toward an increasingly aged society, the number of individuals with cancer increases and with it the need to give the most comprehensive possible health care delivery. Although much has been written about the specific therapy best suited for the various types of cancer and about the basic and clinical research which has dramatically improved treat- ment, overall patient care requires attention to supportive care, which includes such items as pain management, the use of blood products, nutrition, and psychosocial needs. Yet infection remains the leading cause of death in cancer patients and is a major cause of morbidity and hospitaliza- tion, making it a major aspect of the supportive care of cancer patients. It therefore deserves a full exposition. Bone marrow transplantation is increasingly being utilized as part of a therapeutic modality in the treatment of cancer patients.
Transplantation patients are at such a particularly high risk of developing a wide variety of different types of infection, that they inevitably can serve as an excellent framework for discussion of all the types of infections that occur during the treatment of cancer. The patient undergoing allogeneic bone marrow transplantation is at particularly high risk of infection due to the major perturbations of host defenses, which include granulo- cytopenia, cellular immune dysfunction, humoral immune dysfunction, blood product transfusions, and vascular access devices. Each of these perturbations results in a different set of infectious disease problems.
Table of Contents
I. Introduction.- Bone Marrow Transplantation for Cancer: An Overview.- Infection in Bone Marrow Transplantation: A Model for Examining Predisposing Factors to Infection in Cancer Patients.- II. Case Presentation.- to Case Presentation.- III. Infection and Granulocytopenia.- Initial Empiric Therapy for Fever in Neutropenia.- Approach to the Patient with Prolonged Granulocytopenia.- Simplification of Empiric Therapy for the Febrile Neutropenic Oncology Patient.- Fever and Granulocytopenia: A Viewpoint from an Academic Setting.- Empiric Antimicrobial Therapy in the Community Hospital Setting for the Cancer Patient with Fever and Neutropenia: The Need for Vigilance and Attention to Detail.- Observations on the Effects of Hematopoietic Colony Stimulating Factors on the Clinical Course of Bone Marrow Transplantation.- Effect of Colony-Stimulating Factors on Granulocyte Function.- Invasive Aspergillosis: Host Defenses.- Invasive Aspergillosis: Serologic Diagnosis.- Aspergillosis in the Immunocompromised: Focus on Treatment.- Invasive Candidiasis During Granulocytopenia.- IV. Infections and Cellular Immune Dysfunction.- Infections in Cancer Patients with Suppressed Cellular Immunity.- Herpes Simplex Infections.- Treatment and Prophylaxis of Cytomegalovirus Infection After Bone Marrow Transplantation.- Varicella Zoster Infections in Bone Marrow Transplants.- Graft-Versus-Host Disease: Basic Considerations.- Graft-Versus-Host Disease: Implications.- V. Infections Related to Humoral Immune Deficiency/ Vascular Access/Transfusions.- Late Bacterial Infections in Humoral Immune Deficiency.- Hepatitis B and C: Influence of Immunosuppression.- Emergence of Gram-Positive Infections: Relationship to Indwelling Catheters and Management During Chemotherapy-Induced Aplasia.- VI. New Pathogens/Resistance/Drug Delivery.- New Pathogens in the Immunocompromised Host.- Resistant Bacterial Infections.- VII. Clinical Trials: Perspectives.- Organization of Clinical Trials: Problems, Controversies, Definitions, and Methodology Related to Infections in Neutropenic Patients.- Organization of Clinical Trials: Problems, Controversies, Definitions, Methodology.- Case Presentation with Answers to Questions.
by "Nielsen BookData"